Sanofi

RANK289

As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination

Investors send global stocks higher on vaccine hopes and stimulus goodies—but tech shares continue to lag

Sanofi, GlaxoSmithKline reach multi-billion dollar deal with U.S. for coronavirus vaccine

U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine

France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries